The advantages of online therapy

The advantages of online therapy

May 20, 2020

Online therapy provides users access to a variety of therapy services offered by qualified and skilled practitioners from the comfort of their own home. There is no denying technology has impacted nearly every aspect of life and therapy is no exception. Secure platforms have been developed to allow the general public to connect with a licensed therapist through a variety of mediums including chat rooms, phone calls, and video sessions. Nowadays, there are different tools that support online therapy, from telehealth applications to smartphone applications. 

The advantages of online therapy are several, from closing the gap between a shortage of qualified mental health professionals in an area to reaching out people who live in rural areas, far away from a clinic. Additionally, online therapy can also reach people who have very busy schedules and can’t spare the commute, or those are not too comfortable with face to face appointments. 

The main advantages of online therapy are the following:

More personalised treatment

Telehealth and mHealth solutions are tools that can be used to personalise the treatment of individuals with a mental illness. Based on the individual, you can select the tools and features a person could find useful, such as pushing clinical questionnaires on their smartphones, answering electronic self-assessments, accessing psychoeducation, scheduling video sessions or teaching them self-care.

Furthermore, since the use of eHealth itself can help individuals to access psycho-education online, this means more time spent on face-to-face or online sessions.

Patient empowerment

Mental health professionals offer their patients therapy and counselling, however, without the person’s motivation to get better and hard work therapy may not be enough. Digital tools are designed to keep individuals motivated and have a more active role in their treatment, which tends to produce better results.

Nevertheless, digital tools are not only about motivating, but they also help with patient empowerment since they track a person’s behaviour over time, so they can take credit for their progress over time.

Teaches self-care

Therapists offer the best therapy and guidance they can, unfortunately, they cannot always be there to help; therefore, individuals need to learn to face their problems alone. By providing these individuals with an mHealth solution, they have access to valuable information that can be useful if their symptoms appear, and write down any comments on how they felt, so clinicians and individuals can review the situation together.

Helps people who otherwise wouldn’t receive any treatment

Many people who need mental health treatment have to wait endlessly to get an appointment if they manage to get any treatment at all, however, the demand for mental health services is on the rise. This problem can be easily solved with online therapy, which has proven to be, over the last few years, as efficient in-person therapy.

Scalable and cost-effective treatment

One of the greatest challenges the healthcare systems face is the long-term care of individuals with severe mental disorders, such as schizophrenia, since the impact this has on individuals, families and societies is huge. Fortunately, some of these issues can be partially solved with the use of mHealth technology since it helps healthcare professionals to have under their care more individuals with fewer resources.

As Dr Margaret Chan, former Director-General of the World Health Organization,  said: “We must find ways to make sure that access to mental health services becomes a reality for all men, women and children, wherever they live.”

Interview with Monsenso’s Chairman Jukka Pertola

Interview with Monsenso’s Chairman Jukka Pertola

May 12, 2020

Q&A with Monsenso’s Chairman Jukka Pertola

Describe your role in the company
“I joined the company because I have an understanding of IT and software and long-standing experience of working on different boards. When a small company like Monsenso is going public, all the governance structures need to be in place, and that is where I come in. I have previously taken GomSpace to First North in Stockholm. When I joined GomSpace as Chairman of the Board, there were 30 employees, and today they are 150 with a sizeable turnover.”

What is your most important contribution as Chairman of the Board?
“My most important contribution as the Chairman of the Board will be to establish a solid governance structure for when the company goes public. It is my goal to ensure that Monsenso is successfully noted on Nasdaq First North Growth Market this summer.”

 Why did you choose Monsenso?
“Monsenso is an exciting, small company that works within a field where the demand for smart IT-solutions is enormous. The company has a clear positive impact and a very well-defined purpose, and I am proud of the of it, that is why I chose to become the chairman.

Besides, mental health problems are widespread, and according to many publications, hospitals lack the capacity and resources to treat people with mental health problems adequately.

Healthcare professionals need new and effective tools to improve patient-clinician communication and to optimize treatment, and that is a mission I am happy to help support. The pending stock exchange listing will raise capital to the future growth and Monsenso has a significant global potential with it’s certified mobile health solution.”

Can you say a few words about your relationship with Monsenso’s  CEO and CSO
“I know Monsenso’s CEO, Thomas Lethenborg from Siemens, where we worked together closely. Thomas is a competent and experienced leader with a comprehensive understanding of IT and technology, including software services. I believe he is right for Monsenso, and I am looking forward to taking the company public this summer.

I also have a deep trust in Jakob Bardram, who is a respected professor at DTU, and the CTO of Monsenso. Jakob and I have also worked closely, during my time at Siemens. Jakob combines technical knowledge with a deep understanding of mental healthcare, ensuring that Monsenso’s mHealth solution is research-based and certified.”

Why did Monsenso decide to go public during the Corona crisis?
“It is a very uncertain market at the moment, and many companies are postponing their listings. However, since physical contact and doctor’s appointments are minimal at the moment,  all types of mobile health solutions are in high demand, and the Monsenso mHealth solution is a fantastic tool for mental healthcare professionals. Furthermore, when the world is becoming more uncertain and volatile, and we are subject to being somehow isolated in our homes, the need for mental health solutions like the one offered by Monsenso will increase. That is why we are maintaining our plans of going public in June.”

To read more about Monsenso’s intention to go public click on this link: https://www.monsenso.com/monsenso-is-ready-for-the-stock-exchange-after-continuous-growth/

For additional information contact:

Jennifer Highland
Marketing, Monsenso
marketing@monsenso.com

 
Monsenso applies for inclusion on Nasdaq First North Growth Market Denmark

Monsenso applies for inclusion on Nasdaq First North Growth Market Denmark

May 11, 2020

Copenhagen, Denmark – 11 May  2020 – Monsenso has published today a company description detailing the company’s share offer and its plans to trade on Nasdaq First North Growth Market Denmark.

Monsenso’s mobile health solution for mental health is going public, and private Danish investors are invited to participate in Monsenso’s global expansion.

With a scalable and highly sought-after solution within mobile healthcare, Danish company Monsenso has managed to deliver growth in revenue, increase the number of customers, and deliver profits. Now the success must continue globally, which is why Monsenso decided to list on Nasdaq First North Growth Market Denmark. This will allow Danish private investors to join Monsenso’s global expansion of a clinically validated and certified mobile health solution.

The Monsenso mHealth solution has improved the treatment and quality of life for thousands of people affected by mental illness. It has estimated that the number of potential users in Europe alone, is 125 million people, who are affected by mental illness every year. The solution hits a market for mobile healthcare solutions, which is expected to increase on average 40% per year during the upcoming years.

Thomas Lethenborg, CEO of Monsenso, says:

“Our decision to go public has brought positive response both from customers, potential investors, and from the entire team, who has worked hard to get here. I am particularly pleased with the support; we have received from the 40 investors who have made prior commitments to buy shares. This includes Monsenso’s management, the board and employees, who have decided to be co-investors on the journey that we are now beginning.

We have succeeded in establishing ourselves as a strong player in new exciting markets, and now we can develop the company further for the benefit of our users, customers, employees, as well as our shareholders.

The planned IPO is an important milestone in Monsenso’s development. The IPO gives the company a stronger foundation for the continued development of its solution as well as a stronger sales and support set-up. It  strengthens Monsenso’s potential to grow in mHealth market, which is expected to grow significantly during the upcoming years”.

The Company Description, the brochure, as well as further information is available for Denmark-based investors on  www.monsenso.com/investors and potential investors can register for one of the virtual investor meetings on www.monsenso.com/ipo.

For more information:

Monsenso
CEO Thomas Lethenborg
Tel: +45  21 29 88 27
E-mail: Lethenborg@monsenso.com

A smartphone app that supports patient empowerment

A smartphone app that supports patient empowerment

May 1, 2020

“A smartphone app that supports patient empowerment” – Mads Trier-Blom, a Monsenso user, talks about his experience using the Monsenso app, and how it has helped him to become more aware of his mood and other parameters, such as sleep, levels of stress and anxiety and the influence these parameters have on his illness, Bipolar Disorder.

Mads Trier-Blom, who is using the Monsenso app as part of a clinical trial, says the app helps him to be more connected with his clinician, Bente who intervenes when she can see that Mads’s is not feeling well, to help him avoid having an episode.

To Mads, having bipolar disorder feels like walking on a tightrope, since he constantly needs to keep his balance, and avoid losing control to a depressive or a manic episode. He thinks the app helps him keep his balance since he needs to registers his mood every day, which makes him more aware of the way he is feeling. The app also helps him identify any mood fluctuations he has during the week.

During the clinical trial, Mads felt more connected to his clinician, Bente. He recalls an instance when he had missed completing his self-assessments for a couple of days, and Bente called him to see how he was doing. At the beginning, since he was not expecting the call, he was a bit confused. However, when she identified herself and the purpose of her call, he relaxed and told her that he had been a bit tense lately, but that he was overall feeling well. This made him feel more aware of his mood and his behaviour as well as more alert.

Monsenso is ready for the stock exchange, after continuous growth for several years

Monsenso is ready for the stock exchange, after continuous growth for several years

Apr 28, 2020

Copenhagen, Denmark – 28 April  2020 – Danish start-up Monsenso is ready for the stock exchange after continuous growth for several years, with its easily scalable and highly demanded mobile health solution for mental healthcare. The Danish start-up Monsenso has managed to deliver growth in revenue, increase its number of customers, and deliver profits.

Monsenso will now leverage this momentum and invite Danish investors on its upcoming global growth journey.

With a certified and scalable mobile health solution, Monsenso’s technology has proven to be a useful tool to achieve better mental health for more people, with significantly lower costs to society as a result.

The demand for the Monsenso mHealth solution is high, and at the same time, the competitive situation is exceptionally favourable. The Monsenso solution is clinically validated, and thus, it differs significantly from the many stand-alone apps that are available online.

Today, the Monsenso mHealth solution has been deployed to 10 different countries. Now, it has the opportunity to scale up further to more markets, as satisfied customers increase their orders, and new customers sign up.

Growth Plan

Monsenso expects to double its revenue in the coming financial year from DKK 9 million in 2020 to DKK 18.5 million in 2021, and accomplish a revenue of DKK 75 million by 2024.

With the IPO, Monsenso aims to raise a total of DKK 20 million to finance the company’s continued growth journey, expand the organization, and be able to scale up the business further in line with growing demand.

Monsenso has chosen to be admitted to trading at NASDAQ First North GM Copenhagen because broader ownership, as well as the transparency and responsibility that the acquisition entails, will make Monsenso a more attractive partner for its customers.

Corona crisis increases the need for the Monsenso mHealth solution

The current global corona crisis is increasing the demand for Monsenso’s mHealth solution because the technology provides an effective solution to the problems faced due to the isolation experienced by hundreds of thousands of people around the world.

The crisis and the accompanying quarantine measures are spurring people to embrace mobile solutions even more. Digitalization has taken a massive leap in a very short time, and mHealth solutions and well as telemedicine portals will be in high-demand.

Monsenso presents this Intention to Float, paving the way for a listing on NASDAQ First North GM in Copenhagen before summer. Monsenso’s management looks forward to this milestone for the company.

CEO Thomas Lethenborg: “Monsenso’s mHealth solution is hitting a huge and unmet global need to help treat mental disorders. With our strong research foundation and a demonstrated proof of business for private and public players, we believe that the time is right to raise funds and continue our global expansion.”

Chairman Jukka Pertola: “The corona crisis is clearly showing that mobile health solutions work well and that there is a great need in the market. When, during a crisis like corona, physical contact is not possible, mobile health solutions like Monsenso’s are needed even more. That’s why we stick to our plans for a stock exchange listing. “

CTO Jakob Bardram: “Monsenso offers clinicians an easy-to-use tool to monitor patients remotely. With continuous real-time feedback of data, treatment can be tailored for each patient; this results in a more optimal treatment at a lower cost. In the next phase, we will make the solution more scalable and increase the content of the treatment to meet increasing demand.”

Partnerships

Monsenso has entered into a long-term partnership with one of the world’s leading global pharmaceutical companies to use Monsenso’s healthcare solution to support product launches in select countries in Europe.

Monsenso also collaborates with several customers in Denmark and the UK, including the Capital Region, a number of Danish municipalities, and Exeter University.

In the coming years, Monsenso wants to expand and strengthen its market position, and constantly invest in making the solution more configurable with new treatment options, in order to meet the growing demand from more mental disorders.

For information on how to purchase stock options visit www.monsenso.com/investors/

For additional information contact:

Jennifer Highland
Marketing, Monsenso
marketing@monsenso.com